Sedrak, Mina S |
University Of California Los Angeles
United States |
Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline |
1R01CA280088-01 |
|
Goli Samimi, Ph.D., M.P.H. |
You, Ming |
Methodist Hospital Research Institute
United States |
Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis |
1R01CA280746-01A1 |
|
John Clifford, Ph.D. |
Lindau, Stacy Tessler |
University Of Chicago
United States |
Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy |
1R01CA281301-01A1 |
|
Marjorie Perloff, M.D. |
Lampe, Paul D |
Fred Hutchinson Cancer Center
United States |
Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer |
1R01CA281801-01 |
|
Richard Mazurchuk, Ph.D. |
Shah, Sohrab |
Sloan-Kettering Inst Can Research
United States |
Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer |
1R01CA281928-01 |
|
Christos Patriotis, Ph.D., M.Sc. |
Badve, Sunil S. |
Emory University
United States |
Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms |
1R01CA281932-01A1 |
|
Wendy Wang, Ph.D., M.Sc. |
Ghosh, Jayashri |
Temple Univ Of The Commonwealth
United States |
Development of blood-based methylation biomarkers for CRC risk prediction |
1R01CA281948-01 |
|
Matthew Young, Ph.D. |
Hoshida, Yujin |
Ut Southwestern Medical Center
United States |
Epigallocatechin gallate for prevention of lethal cirrhosis complications |
1R01CA282178-01 |
|
Asad Umar, D.V.M., Ph.D. |
Bower, Julienne E |
University Of California Los Angeles
United States |
Mindfulness Meditation for Younger Breast Cancer Survivors: Testing Digital Interventions in Clinical and Community Settings |
1R01CA282416-01A1 |
|
Brennan Streck, Ph.D., R.N., M.P.H. |
Sands, Stephen Alan |
Sloan-Kettering Inst Can Research
United States |
Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) |
1R01CA283045-01 |
PAR-21-329 (R01 Clinical Trial Optional) |
Catherine Schweppe, Ph.D. |